Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
Creator
Zheng, Bo-Jian
Jin, Dong-Yan
Yuen, Kwok-Yung
Zhou, Jie
Leung, Ho-Chuen
Chu, Hin
Lin, Yong-Ping
Fai, Ng
Liu, Dabin
Zhang, Ke
Zhao, Hanjun
Chan, Chung-Sing
Kwok-Man, Vincent
Poon,
Zhang, Jin-Xia
Source
Medline; PMC
abstract
A safe, potent and broad-spectrum antiviral is urgently needed to combat emerging respiratory viruses. In light of the broad antiviral activity of β-defensins, we tested the antiviral activity of 11 peptides derived from mouse β-defensin-4 and found that a short peptide, P9, exhibited potent and broad-spectrum antiviral effects against multiple respiratory viruses in vitro and in vivo, including influenza A virus H1N1, H3N2, H5N1, H7N7, H7N9, SARS-CoV and MERS-CoV. The antiviral activity of P9 was attributed to its high-affinity binding to viral glycoproteins, as well as the abundance of basic amino acids in its composition. After binding viral particles through viral surface glycoproteins, P9 entered into cells together with the viruses via endocytosis and prevented endosomal acidification, which blocked membrane fusion and subsequent viral RNA release. This study has paved the avenue for developing new prophylactic and therapeutic agents with broad-spectrum antiviral activities.
has issue date
2016-02-25
(
xsd:dateTime
)
bibo:doi
10.1038/srep22008
bibo:pmid
26911565
has license
cc-by
sha1sum (hex)
61c8af64ef0a95e3f6dfc71ced3f94c2768e23d2
schema:url
https://doi.org/10.1038/srep22008
resource representing a document's title
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
has PubMed Central identifier
PMC4766503
has PubMed identifier
26911565
schema:publication
Sci Rep
resource representing a document's body
covid:61c8af64ef0a95e3f6dfc71ced3f94c2768e23d2#body_text
is
schema:about
of
named entity 'BROAD'
named entity 'peptides'
named entity 'antiviral'
named entity 'antiviral'
named entity 'H1N1'
named entity 'binding'
named entity 'surface'
named entity 'composition'
named entity 'basic'
named entity 'NOVEL'
named entity 'ACTIVITIES'
named entity 'H3N2'
named entity 'H5N1'
named entity 'MERS-COV'
named entity 'RELEASE'
named entity 'ACIDIFICATION'
named entity 'ANTIVIRAL ACTIVITY'
named entity 'GLYCOPROTEINS'
named entity 'EFFECTS'
named entity 'BINDING'
named entity 'SARS-COV'
named entity 'MEMBRANE FUSION'
named entity 'PEPTIDE'
named entity 'COMPOSITION'
named entity 'ENTERED'
named entity 'IN VITRO'
named entity 'COMBAT'
named entity 'MULTIPLE'
named entity 'FOUND'
named entity 'HIGH'
named entity 'BLOCKED'
named entity 'NEW'
named entity 'ENDOCYTOSIS'
named entity 'ITS'
named entity 'SPECTRUM'
named entity 'DEVELOPING'
named entity 'SUBSEQUENT'
named entity 'AFFINITY'
named entity 'STUDY'
named entity 'H1N1'
named entity 'SPECTRUM'
named entity 'DERIVED'
named entity 'ABUNDANCE'
named entity 'ANTIVIRAL'
named entity 'VIRAL PARTICLES'
named entity 'SHORT'
named entity 'ANTIVIRAL'
named entity 'VIRUSES'
named entity 'PROPHYLACTIC'
named entity 'PEPTIDES'
named entity 'IN VIVO'
named entity 'H7N9'
named entity 'AVENUE'
named entity 'TESTED'
named entity 'DEFENSIN'
named entity 'SAFE'
named entity 'OPEN'
named entity 'MULTIPLE'
named entity 'INCLUDING'
named entity 'BROAD'
named entity 'MOUSE'
named entity 'NEEDED'
named entity 'DEFENSINS'
named entity 'VIRAL'
named entity 'RESPIRATORY VIRUSES'
named entity 'BASIC AMINO ACIDS'
named entity 'RESPIRATORY VIRUSES'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software